Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
ESMO Gastrointestinal Oncology|February 6, 2026
Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotypingJ Sgouros, A Eliades, K Papadopoulou, et al.
Clinical Breast Cancer|May 22, 2012
Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expressionEvangelia Razis, Konstantine T Kalogeras, Vassiliki Kotoula, et al.
Anticancer Research|April 13, 2016
HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group StudyThomas Makatsoris, Athanassios C Tsamandas, Alexios Strimpakos, et al.
Oncotarget|May 17, 2018
Deregulation of methylation of transcribed-ultra conserved regions in colorectal cancer and their value for detection of adenomas and adenocarcinomasAnastasia E Kottorou, Anna G Antonacopoulou, Foteinos-Ioannis D Dimitrakopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2006
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, P Papakostas, U Dafni, et al.
Clinical Colorectal Cancer|September 21, 2013
The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximabAlexios Strimpakos, George Pentheroudakis, Vassiliki Kotoula, et al.
Plos One|May 14, 2015
Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trialGeorge Pentheroudakis, Georgia Raptou, Vassiliki Kotoula, et al.
Plos One|March 29, 2013
Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer casesAlexandra V Stavropoulou, Florentia Fostira, Maroulio Pertesi, et al.
Anticancer Research|November 2, 2010
Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancerHaralabos P Kalofonos, Pavlos Papakostas, Thomas Makatsoris, et al.
Clinical Colorectal Cancer|August 13, 2019
Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and BevacizumabGeorge Pentheroudakis, Leonidas Mavroeidis, Kyriaki Papadopoulou, et al.
Pageof 11